96Indexed trials
Market Rank #25 · Evidence Tier A
Hungary
Neuroscience Intelligence
Hungary neuroscience intelligence: 96 indexed trials, 15 institutions, research score 30.11.
20Recruiting
15Research institutions
30.1Research score
Evidence profile
56Sponsors
17Disease areas
0Institution works
0Institution citations
Model signals
Opportunity 30 · ML priority 30 · Confidence 85 · Evidence 30.1
These are comparative evidence signals. They do not represent a guarantee of market size or commercial outcome.
Leading disease areas
parkinsons24trials
epilepsy16trials
alzheimers9trials
multiple_sclerosis7trials
autism5trials
schizophrenia5trials
depression4trials
stroke3trials
traumatic_brain_injury1trials
bipolar_disorder1trials
Leading indexed sponsors
Merck Sharp & Dohme LLC12trials
Hoffmann-La Roche7trials
Boehringer Ingelheim4trials
Eisai Limited3trials
UCB Pharma3trials
GlaxoSmithKline3trials
Novo Nordisk A/S3trials
Pfizer's Upjohn has merged with Mylan to form Viatris Inc.3trials
Forest Laboratories2trials
H. Lundbeck A/S2trials